Jun 14, 2026 02:01PM
Jun 14, 2026 10:00AM
Jun 8, 2026 07:00AM
Jun 3, 2026 06:01AM
Jun 3, 2026 06:00AM
Jun 1, 2026 01:46PM
May 30, 2026 11:15AM Mineralys presents lorundrostat data for hypertension patients with kidney disease
May 30, 2026 11:15AM
May 30, 2026 11:15AM
May 18, 2026 04:05PM
May 18, 2026 04:05PM
May 6, 2026 04:05PM
Mar 24, 2026 08:00AM
Mar 24, 2026 08:00AM Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
Mar 13, 2026 07:59AM
Mar 12, 2026 04:05PM
Mar 10, 2026 09:32AM
Mar 10, 2026 06:12AM
Mar 9, 2026 04:30PM
Mar 3, 2026 05:31PM
Jan 6, 2026 08:00AM Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026
Dec 12, 2025 11:00AM
Dec 12, 2025 11:00AM
Nov 10, 2025 04:05PM
Nov 7, 2025 06:10PM
Oct 21, 2025 08:00AM
Oct 21, 2025 08:00AM
Sep 30, 2025 08:01AM Mineralys completes enrollment in sleep apnea drug trial
Sep 30, 2025 08:00AM
Sep 8, 2025 07:13AM
Sep 5, 2025 09:00AM
Sep 5, 2025 09:00AM
Aug 12, 2025 04:05PM
Jul 14, 2025 08:20AM
Jun 30, 2025 11:19AM Mineralys Therapeutics (MLYS) announces positive results from Phase 3 Launch-HTN trial
Jun 30, 2025 11:17AM
Jun 18, 2025 06:44AM
Jun 17, 2025 07:00AM
Jun 17, 2025 07:00AM
May 24, 2025 04:30AM
May 20, 2025 08:01AM
May 20, 2025 08:00AM Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection
May 12, 2025 04:05PM
Apr 23, 2025 05:25PM
Apr 23, 2025 05:23PM
Mar 29, 2025 02:30PM
Mar 17, 2025 08:00AM
Mar 17, 2025 08:00AM
Mar 10, 2025 07:01AM Mineralys Therapeutics (MLYS) Announces Positive Topline Results from Launch-HTN and Advance-HTN Trials of Lorundrostat
Mar 10, 2025 07:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All